Literature DB >> 16742589

Properties of beta-lactamases produced by three species of mycobacteria.

J E Kasik1, L Peacham.   

Abstract

1. Mycobacterium smegmatis (N.C.T.C. 8158), M. fortuitum and M. phlei (MPI) produce a constitutive beta-lactamase that has penicillinase and cephalosporinase activity. 2. The beta-lactamases of these three species of acid-fast bacteria were mainly cell-bound, only small amounts of activity being liberated into the extracellular fluid. The total beta-lactamase activity of these mycobacteria was much lower than that of certain Gram-positive organisms, but comparable with that reported for species of Gram-negative bacteria. 3. The beta-lactamases of intact cells of the mycobacteria were not freely accessible to any of the substrates tested, but the apparent crypticity factor to benzylpenicillin was greater than that to cephaloridine and cephalosporin C. 4. Attempts to induce beta-lactamase activity in M. smegmatis and M. phlei failed even with high concentrations of inducer. 5. The beta-lactamases obtained from the three species of mycobacteria showed different substrate specificities, including different relative activities as cephalosporinases and penicillinases respectively. 6. Certain derivatives of 6-aminopenicillanic acid and 7-aminocephalosporanic acid were found to be resistant to hydrolysis by beta-lactamases of M. smegmatis and M. fortuitum. 7. The beta-lactamase of M. smegmatis was competitively inhibited by a number of beta-lactamase-resistant derivatives of 6-aminopenicillanic acid, but not by similar derivatives of 7-aminocephalosporanic acid.

Entities:  

Year:  1968        PMID: 16742589      PMCID: PMC1198720          DOI: 10.1042/bj1070675

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  INHIBITION OF PENICILLINASES FROM GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA BY SUBSTRATE ANALOGUES.

Authors:  J M HAMILTON-MILLER; J T SMITH
Journal:  Nature       Date:  1964-03-07       Impact factor: 49.962

2.  THE ROLE OF PENICILLINASE IN DETERMINING NATURAL AND ACQUIRED RESISTANCE OF GRAM-NEGATIVE BACTERIA TO PENICILLINS.

Authors:  A PERCIVAL; W BRUMFITT; J DE LOUVOIS
Journal:  J Gen Microbiol       Date:  1963-07

3.  PURIFICATION AND PROPERTIES OF THE EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1963-09       Impact factor: 3.857

4.  POTENTIATION OF PENICILLIN ACTION BY INHIBITION OF PENICILLINASE.

Authors:  J M HAMILTON-MILLER; J T SMITH; R KNOX
Journal:  Nature       Date:  1964-02-29       Impact factor: 49.962

5.  PRODUCTION OF A CEPHALOSPORINASE BY PSEUDOMONAS PYOCYANEA.

Authors:  M JAGO; A MIGLIACCI; E P ABRAHAM
Journal:  Nature       Date:  1963-07-27       Impact factor: 49.962

6.  Status of disease due to unclassified mycobacteria. A statement of the Subcommittee on Unclassified Mycobacteria of the Committee on Therapy.

Authors:  R F CORPE; E H RUNYON; W LESTER
Journal:  Am Rev Respir Dis       Date:  1963-03

7.  Penicillinase from Klebsiella aerogenes. A comparison with penicillinases from gram-positive species.

Authors:  J M HAMILTON-MILLER
Journal:  Biochem J       Date:  1963-04       Impact factor: 3.857

8.  Penicillinase and ampicillin resistance in a strain of Escherichia coli.

Authors:  J T SMITH
Journal:  J Gen Microbiol       Date:  1963-02

9.  Ampicillin inactivation and sensitivity of coliform bacilli.

Authors:  G A AYLIFFE
Journal:  J Gen Microbiol       Date:  1963-02

10.  Low cyst(e)ine content of bacterial extracellular proteins: its possible physiological significance.

Authors:  M R POLLOCK; M H RICHMOND
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

View more
  9 in total

Review 1.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

2.  Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra.

Authors:  C J Hackbarth; I Unsal; H F Chambers
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Immunological distinction of mycobacterial beta-lactamases.

Authors:  J S Thompson; C D Severson; N A Stearns; J E Kasik
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

4.  Resistance of Escherichia coli to penicillins. VI. Purification and characterization of the chromosomally mediated penicillinase present in ampA-containing strains.

Authors:  E B Linström; H G Boman; B B Steele
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

5.  Characterization of a beta-lactamase produced in Mycobacterium fortuitum D316.

Authors:  G Amicosante; N Franceschini; B Segatore; A Oratore; L Fattorini; G Orefici; J Van Beeumen; J M Frere
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.

Authors:  L Fattorini; G Scardaci; S H Jin; G Amicosante; N Franceschini; A Oratore; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.

Authors:  M H Cynamon; G S Palmer
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 8.  Molecular biology of drug resistance in Mycobacterium tuberculosis.

Authors:  Tasha Smith; Kerstin A Wolff; Liem Nguyen
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.

Authors:  Albert B Jeon; Andrés Obregón-Henao; David F Ackart; Brendan K Podell; Juan M Belardinelli; Mary Jackson; Tuan V Nguyen; Meghan S Blackledge; Roberta J Melander; Christian Melander; Benjamin K Johnson; Robert B Abramovitch; Randall J Basaraba
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.